Insider Trading activities at Albireo Pharma, Inc. (BIOD)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Albireo Pharma, Inc. (BIOD) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Albireo Pharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1322505.

Total stock buying since 2015: $30,497,924.
Total stock sales since 2015: $30,102,003.
Total stock option exercises since 2015: $1,821,334.


13 insiders reported insider trading activities at Albireo Pharma, Inc. (BIOD):
Insider trading activities of Mattsson Jan
Insider trading activities of Graham Michelle
Insider trading activities of Desouza Errol B
Insider trading activities of Brown Julia R
Insider trading activities of Horn Patrick Taylor
Insider trading activities of Stephenson Pamela
Insider trading activities of Carter Martha J.
Insider trading activities of Astrazeneca Ab
Insider trading activities of Phase4 Ventures Iii Lp
Insider trading activities of Harford Simon N.r.
Insider trading activities of Cooper Ronald Harold Wilfred
Insider trading activities of Edelman Joseph
Insider trading activities of Duncan Jason

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Albireo Pharma, Inc. (BIOD).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2023 0 $0 12,076 $529,485 0 $0
2022 0 $0 438,842 $10,140,414 0 $0
2021 0 $0 52,576 $1,913,276 67,903 $675,274
2020 655,809 $21,371,989 58,911 $2,432,429 43,500 $1,005,989
2018 276,814 $9,125,935 125,000 $4,386,399 11,166 $140,071
2017 0 $0 500,000 $10,700,000 0 $0
2015 0 $0 0 $0 131,128 $0

Table 2. Monthly summary of insider trading at Albireo Pharma, Inc. (BIOD).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2023-01 0 $0 12,076 $529,485 0 $0
2022-12 0 $0 469 $8,939 0 $0
2022-10 0 $0 422,689 $9,735,217 0 $0
2022-09 0 $0 2,225 $43,175 0 $0
2022-07 0 $0 2,310 $56,692 0 $0
2022-06 0 $0 461 $8,975 0 $0
2022-04 0 $0 2,270 $75,354 0 $0
2022-03 0 $0 454 $13,858 0 $0
2022-01 0 $0 7,964 $198,204 0 $0
2021-12 0 $0 474 $11,339 0 $0
2021-10 0 $0 500 $14,627 0 $0
2021-09 0 $0 451 $14,456 11,973 $229,761
2021-07 0 $0 501 $16,581 0 $0
2021-06 0 $0 16,300 $591,986 16,300 $398,971
2021-04 0 $0 702 $23,736 300 $7,212
2021-03 0 $0 33,318 $1,228,829 39,330 $39,330
2021-01 0 $0 330 $11,722 0 $0
2020-12 0 $0 460 $17,974 0 $0
2020-10 0 $0 268 $9,519 0 $0
2020-09 400,000 $16,000,000 54,451 $2,325,072 43,500 $1,005,989
2020-07 0 $0 274 $7,045 0 $0
2020-06 0 $0 397 $12,223 0 $0
2020-04 0 $0 281 $4,850 0 $0
2020-03 0 $0 1,785 $31,416 0 $0

Table 3. Detailed insider trading at Albireo Pharma, Inc. (BIOD)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2023-01-23 Stephenson Pamela (Chief Commercial Officer) Sale 102 43.80 4,467
2023-01-23 Duncan Jason (Chief Legal Officer and GC) Sale 228 43.80 9,986
2023-01-23 Mattsson Jan (Chief Scientific Officer) Sale 197 43.80 8,628
2023-01-23 Cooper Ronald Harold Wilfred (President and CEO) Sale 1,057 43.80 46,296
2023-01-23 Graham Michelle (Chief Human Resources Officer) Sale 102 43.80 4,467
2023-01-23 Harford Simon N.r. (CFO and Treasurer) Sale 102 43.80 4,467
2023-01-19 Stephenson Pamela (Chief Commercial Officer) Sale 1,774 43.90 77,885
2023-01-19 Duncan Jason (Chief Legal Officer and GC) Sale 938 43.90 41,181
2023-01-19 Mattsson Jan (Chief Scientific Officer) Sale 3,088 43.80 135,254
2023-01-19 Graham Michelle (Chief Human Resources Officer) Sale 1,774 43.90 77,885
2023-01-19 Harford Simon N.r. (CFO and Treasurer) Sale 1,776 43.80 77,788
2023-01-19 Carter Martha J. (Chief Regulatory Officer) Sale 938 43.90 41,181
2022-12-27 Stephenson Pamela (Chief Commercial Officer) Sale 469 19.06 8,939
2022-10-24 Stephenson Pamela (Chief Commercial Officer) Sale 104 19.58 2,035
2022-10-24 Duncan Jason (Chief Legal Officer and GC) Sale 656 19.50 12,793
2022-10-24 Mattsson Jan (Chief Scientific Officer) Sale 202 19.58 3,954
2022-10-24 Cooper Ronald Harold Wilfred (President and CEO) Sale 919 19.58 17,990
2022-10-24 Graham Michelle (Chief Human Resources Officer) Sale 104 19.58 2,035
2022-10-24 Harford Simon N.r. (CFO and Treasurer) Sale 104 19.58 2,035
2022-10-24 Carter Martha J. (Chief Regulatory Officer) Sale 104 19.58 2,035
2022-10-13 Edelman Joseph (10% Owner) Sale 179,132 22.40 4,012,556
2022-10-12 Edelman Joseph (10% Owner) Sale 97,219 22.75 2,211,246
2022-10-11 Harford Simon N.r. (CFO and Treasurer) Sale 80 23.79 1,902
2022-10-11 Edelman Joseph (10% Owner) Sale 144,065 24.06 3,466,636
2022-09-26 Stephenson Pamela (Chief Commercial Officer) Sale 1,335 19.41 25,905
2022-07-25 Duncan Jason (Chief Legal Officer and GC) Sale 313 24.02 7,519
2022-07-22 Stephenson Pamela (Chief Commercial Officer) Sale 106 24.67 2,615
2022-07-22 Duncan Jason (Chief Legal Officer and GC) Sale 344 24.56 8,450
2022-07-22 Mattsson Jan (Chief Scientific Officer) Sale 205 24.68 5,058
2022-07-22 Cooper Ronald Harold Wilfred (President and CEO) Sale 929 24.68 22,923
2022-07-22 Graham Michelle (Chief Human Resources Officer) Sale 106 24.67 2,615
2022-07-22 Harford Simon N.r. (CFO and Treasurer) Sale 106 24.67 2,615
2022-07-22 Carter Martha J. (Chief Regulatory Officer) Sale 106 24.68 2,615
2022-07-12 Harford Simon N.r. (CFO and Treasurer) Sale 95 24.03 2,282
2022-06-27 Stephenson Pamela (Chief Commercial Officer) Sale 461 19.47 8,975
2022-04-25 Duncan Jason (Chief Legal Officer and GC) Sale 312 33.42 10,427
2022-04-22 Stephenson Pamela (Chief Commercial Officer) Sale 103 32.92 3,391
2022-04-22 Duncan Jason (Chief Legal Officer and GC) Sale 343 33.00 11,318
2022-04-22 Mattsson Jan (Chief Scientific Officer) Sale 200 32.92 6,584
2022-04-22 Cooper Ronald Harold Wilfred (President and CEO) Sale 907 33.11 30,030
2022-04-22 Graham Michelle (Chief Human Resources Officer) Sale 103 32.92 3,391
2022-04-22 Harford Simon N.r. (CFO and Treasurer) Sale 103 32.92 3,391
2022-04-22 Carter Martha J. (Chief Regulatory Officer) Sale 103 32.92 3,391
2022-04-11 Harford Simon N.r. (CFO and Treasurer) Sale 96 35.74 3,431
2022-03-28 Stephenson Pamela (Chief Commercial Officer) Sale 454 30.52 13,858
2022-01-24 Stephenson Pamela (Chief Commercial Officer) Sale 416 24.88 10,350
2022-01-24 Duncan Jason (Chief Legal Officer and GC) Sale 1,688 24.97 42,152
2022-01-24 Mattsson Jan (Chief Scientific Officer) Sale 808 24.88 20,104
2022-01-24 Cooper Ronald Harold Wilfred (President and CEO) Sale 3,684 24.88 91,665
2022-01-24 Graham Michelle (Chief Human Resources Officer) Sale 418 24.72 10,333
2022-01-24 Harford Simon N.r. (CFO and Treasurer) Sale 416 24.88 10,350
2022-01-24 Carter Martha J. (Chief Regulatory Officer) Sale 423 24.52 10,370
2022-01-11 Harford Simon N.r. (CFO and Treasurer) Sale 111 25.95 2,880
2021-12-27 Stephenson Pamela (Chief Commercial Officer) Sale 474 23.92 11,339
2021-10-25 Duncan Jason (Chief Legal Officer and GC) Sale 217 29.21 6,338
2021-10-22 Duncan Jason (Chief Legal Officer and GC) Sale 95 28.85 2,740
2021-10-22 Horn Patrick Taylor (Chief Medical Officer) Sale 95 28.83 2,738
2021-10-11 Harford Simon N.r. (CFO and Treasurer) Sale 93 30.23 2,811
2021-09-27 Stephenson Pamela (Chief Commercial Officer) Sale 451 32.05 14,456
2021-09-17 Cooper Ronald Harold Wilfred (President and CEO) Option Ex 11,973 19.19 229,761
2021-07-23 Duncan Jason (Chief Legal Officer and GC) Sale 223 31.43 7,008
2021-07-22 Duncan Jason (Chief Legal Officer and GC) Sale 90 34.13 3,071
2021-07-22 Horn Patrick Taylor (Chief Medical Officer) Sale 90 34.13 3,071
2021-07-13 Harford Simon N.r. (CFO and Treasurer) Sale 98 35.02 3,431
2021-06-25 Duncan Jason (Chief Legal Officer and GC) Sale 6,300 36.22 228,186
2021-06-25 Duncan Jason (Chief Legal Officer and GC) Option Ex 6,300 24.67 155,421
2021-06-24 Duncan Jason (Chief Legal Officer and GC) Sale 10,000 36.38 363,800
2021-06-24 Duncan Jason (Chief Legal Officer and GC) Option Ex 10,000 24.36 243,550
2021-04-23 Duncan Jason (Chief Legal Officer and GC) Sale 222 32.32 7,175
2021-04-22 Duncan Jason (Chief Legal Officer and GC) Sale 90 31.75 2,857
2021-04-22 Horn Patrick Taylor (Chief Medical Officer) Sale 90 31.75 2,857
2021-04-01 Duncan Jason (Chief Legal Officer and GC) Sale 300 36.16 10,847
2021-04-01 Duncan Jason (Chief Legal Officer and GC) Option Ex 300 24.04 7,212
2021-03-31 Duncan Jason (Chief Legal Officer and GC) Sale 1,426 35.04 49,969
2021-03-29 Stephenson Pamela (Chief Commercial Officer) Sale 422 34.02 14,355
2021-03-03 Mattsson Jan (Chief Scientific Officer) Sale 400 36.20 14,481
2021-03-02 Mattsson Jan (Chief Scientific Officer) Sale 15,770 36.59 577,024
2021-03-01 Mattsson Jan (Chief Scientific Officer) Sale 15,300 37.45 573,000
2021-03-01 Mattsson Jan (Chief Scientific Officer) Option Ex 39,330 1.00 39,330
2021-01-22 Duncan Jason (Chief Legal Officer and GC) Sale 110 34.62 3,808
2021-01-22 Horn Patrick Taylor (Chief Medical Officer) Sale 110 34.62 3,808
2021-01-11 Harford Simon N.r. (CFO and Treasurer) Sale 110 37.33 4,106
2020-12-28 Stephenson Pamela (Chief Commercial Officer) Sale 460 39.07 17,974
2020-10-22 Duncan Jason (Chief Legal Officer and GC) Sale 89 34.71 3,089
2020-10-22 Horn Patrick Taylor (Chief Medical Officer) Sale 89 34.55 3,074
2020-10-12 Harford Simon N.r. (CFO and Treasurer) Sale 90 37.30 3,356
2020-09-25 Stephenson Pamela (Chief Commercial Officer) Sale 451 33.20 14,973
2020-09-14 Edelman Joseph (10% Owner) Buy 400,000 40.00 16,000,000
2020-09-11 Carter Martha J. (Chief Regulatory Officer) Sale 10,000 40.03 400,300
2020-09-11 Carter Martha J. (Chief Regulatory Officer) Option Ex 10,000 27.12 271,200
2020-09-10 Carter Martha J. (Chief Regulatory Officer) Sale 10,000 42.41 424,099
2020-09-10 Carter Martha J. (Chief Regulatory Officer) Option Ex 10,000 24.26 242,600
2020-09-09 Carter Martha J. (Chief Regulatory Officer) Sale 10,000 39.25 392,500
2020-09-09 Carter Martha J. (Chief Regulatory Officer) Option Ex 10,000 21.61 216,149
2020-09-08 Duncan Jason (Chief Legal Officer and GC) Sale 4,000 45.55 182,200
2020-09-08 Duncan Jason (Chief Legal Officer and GC) Option Ex 3,500 24.04 84,140
2020-09-08 Mattsson Jan (Chief Scientific Officer) Sale 10,000 45.55 455,500
2020-09-08 Carter Martha J. (Chief Regulatory Officer) Sale 10,000 45.55 455,500
2020-09-08 Carter Martha J. (Chief Regulatory Officer) Option Ex 10,000 19.19 191,900
2020-07-22 Duncan Jason (Chief Legal Officer and GC) Sale 91 25.80 2,347
2020-07-22 Horn Patrick Taylor (Chief Medical Officer) Sale 91 25.80 2,347
2020-07-10 Harford Simon N.r. (CFO and Treasurer) Sale 92 25.56 2,351
2020-06-25 Stephenson Pamela (Chief Commercial Officer) Sale 397 30.79 12,223
2020-04-22 Duncan Jason (Chief Legal Officer and GC) Sale 92 17.68 1,626
2020-04-22 Horn Patrick Taylor (Chief Medical Officer) Sale 92 17.64 1,622
2020-04-13 Harford Simon N.r. (CFO and Treasurer) Sale 97 16.52 1,602
2020-03-25 Stephenson Pamela (Chief Commercial Officer) Sale 1,785 17.60 31,416
2020-02-03 Edelman Joseph (10% Owner) Buy 255,809 21.00 5,371,989
2020-01-22 Duncan Jason (Chief Legal Officer and GC) Sale 447 23.97 10,714
2020-01-22 Horn Patrick Taylor (Chief Medical Officer) Sale 443 24.29 10,760
2020-01-10 Harford Simon N.r. (CFO and Treasurer) Sale 105 27.20 2,856
2018-11-13 Cooper Ronald Harold Wilfred (President and CEO) Buy 1,026 25.02 25,668
2018-08-14 Cooper Ronald Harold Wilfred (President and CEO) Buy 788 32.06 25,267
2018-06-13 Mattsson Jan (Chief Operating Officer) Sale 6,903 32.08 221,448
2018-06-12 Mattsson Jan (Chief Operating Officer) Sale 18,097 32.71 591,952
2018-06-07 Brown Julia R (Director) Option Ex 7,833 13.40 110,074
2018-01-30 Phase4 Ventures Iii Lp Sale 100,000 35.73 3,572,999
2018-01-25 Edelman Joseph (10% Owner) Buy 275,000 33.00 9,075,000
2017-12-01 Astrazeneca Ab (10% Owner) Sale 500,000 21.40 10,700,000
2015-09-30 Desouza Errol B (CEO) Option Ex 131,128 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of BIOD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Albireo Pharma, Inc. (symbol BIOD, CIK number 1322505) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.